Section Arrow
QURE.NASDAQ
- uniQure NV
Quotes are at least 15-min delayed:2025/07/21 06:44 EDT
Pre Market
Last
 15.2
+0.21 (+1.40%)
Bid
15.15
Ask
15.39
High 15.28 
Low 15.06 
Volume 129 
Regular Hours
Last
 14.99
-0.21 (-1.38%)
Day High 
15.52 
Prev. Close
15.2 
1-M High
15.835 
Volume 
1.80M 
Bid
15.15
Ask
15.39
Day Low
14.6 
Open
15.36 
1-M Low
13.51 
Market Cap 
832.18M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 14.55 
20-SMA 14.38 
50-SMA 14.49 
52-W High 19.18 
52-W Low 4.45 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-4.38/-2.85
Enterprise Value
894.64M
Balance Sheet
Book Value Per Share
0.62
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
27.12M
Operating Revenue Per Share
2.04
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
TELOTelomir Pharmaceuticals2.28+1.07+88.43%-- 
Pre Market 2 -0.28 -12.28%
SRPTSarepta Therapeutics14.075-7.895-35.94%15.76PE
Pre Market 13.12 -0.955 -6.79%
NCNANuCana plc0.0477+0.0009+1.92%-- 
Pre Market 0.0474 -0.0003 -0.63%
RXRXRecursion Pharmaceuticals5.84+0.32+5.80%-- 
Pre Market 6.23 +0.39 +6.68%
MEIPMEI Pharma5.92+1.42+31.56%1.09PE
Pre Market 6.06 +0.14 +2.36%
Quotes are at least 15-min delayed:2025/07/21 06:44 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.